3 Houston innovators to know this week

who's who

This week's roundup of Houston innovators includes Moji Karimi of Cemvita Factory, Shanna Jin of Rice University, and Trent Crow of Real Simple Energy. Courtesy photos

Editor's note: In the week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — data science, consumer tech, and medical device innovation — recently making headlines in Houston innovation.

Moji Karimi, co-founder and CEO of Cemvita Factory

Moji Karimi joins the Houston Innovators Podcast to discuss how his technology is offering energy execs an innovative way to meat their climate change pledge goals. Photo courtesy of Cemvita

A lot of startups are working on technology that makes existing practices more efficient, cheaper, or faster — or all of the above. But Cemvita Factory, founded by siblings Moji and Tara Karimi, is doing something that's never been done before: biomimicking photosynthesis to convert carbon emissions into useful chemicals.

"There weren't biotech companies working with oil and gas companies for this use case that we have now," Moji Karimi says on this week's episode of the Houston Innovators Podcast. "We're defining this new category for application of synthetic biology in heavy industries for decarbonization."

With this uncharted territory comes unique challenges and opportunities. Click here to read more and stream the episode.

Shanna Jin, communications and marketing specialist of the Data to Knowledge Lab at Rice University

Startups and small businesses are accumulating data daily — here's how to use that to your advantage, according to this Houston expert. Photo via rice.edu

Ironically, the power of data management is almost incalculable. With the right practices and processes in place, businesses can make better decisions and grow more strategically. But, it's not something a lot of startups or small businesses look at regularly. That's where the Rice University Data To Knowledge group comes into play.

"Being able to interpret data and making data-driven decisions becomes the key to the success of a business," writes Shanna Jin in a guest column for InnovationMap. "It is not just a privilege for big companies anymore. Small businesses need it more than ever to make sustainable growth in the digital era." Click here to read more.

Trent Crow, founder and president of Real Simple Energy

Trent Crow, founder and president, and the Real Simple Energy team have moved over to Arcardia with the acquisition. Photo courtesy of Real Simple Energy

Earlier this month, a Houston startup exited to a larger tech company. Trent Crow, co-founder and CEO of Real Simply Energy, says all eight of the company's employees have moved over to Arcadia and more workers will be hired soon. The company has maintained a mix of office and remote workers. Arcadia will look for Houston office space later this year, Crow says.

"Expansion plans include doing more of what we're doing now and offering more features for customers," says Crow, who now is Arcadia's general manager of energy services in Texas. Click here to read more.

Trent Crow, founder and president (left), and Paul Paras, founder and vice president, and the rest of the Real Simple Energy team have moved over to Arcardia with the acquisition. Photo courtesy of Real Simple Energy

Houston energy startup acquired by growing tech company

making moves

February's massive winter weather disaster underscored the fragile availability and volatile cost of electricity in the Houston area and throughout Texas. Just a month after the calamity, a Washington, D.C.-based company has scooped up Houston-based Real Simple Energy to help put power back in the hands of electricity consumers in Texas.

Arcadia, a tech company that connects U.S. homeowners and renters to renewable energy, said March 17 that it had purchased Real Simple Energy. Terms of the deal for the three-year-old startup weren't disclosed.

Real Simple Energy's automated platform matches power usage with the lowest rates in the Texas marketplace to reduce electric bills. The company manages all facets of a customer's monthly power bills.

Trent Crow, co-founder and CEO of Real Simply Energy, says all eight of the company's employees have moved over to Arcadia and more workers will be hired soon. The company has maintained a mix of office and remote workers. Arcadia will look for Houston office space later this year, Crow says.

"Expansion plans include doing more of what we're doing now and offering more features for customers," says Crow, who now is Arcadia's general manager of energy services in Texas.

Aside from Crow, co-founders of Real Simple Energy are Paul Paras and Matt Herpich.

Real Simple Energy says its customers save an average of 36 percent, or $548 a year, on electricity. That figure is based on the power bill for a 2,300-square-foot home. The startup says its fixed-rate and fixed-bill plans aren't subject to the types of spikes in power prices that many Texans experienced during February's winter weather disaster.

"Recent events in the Texas market prove that customers shouldn't be exposed to wholesale or variable rates, and want an energy advocate to protect them," Kiran Bhatraju, founder and CEO of Arcadia, says in a release. "Both Arcadia and Real Simple Energy recognize the challenges Texas homeowners and renters have historically faced in the energy-buying process, and we remain committed to removing these confusing barriers. We'll always be on the customer's side, focusing on the best rate and protecting our customers from bad actors."

Crow says the struggle to bring down energy costs at his home prompted him to start the company. He spent several years as a wholesale power trader at JPMorgan Chase.

"The deregulated energy industry, especially in Texas, has underserved customers and, as a result, most customers overpay for electricity and receive poor customer service. Using technology, we are helping customers realize the promise of deregulation and always get the best fixed rates available," Crow says in a release.

This deal represents the first acquisition for Arcadia, founded in 2014. In partnership with 125 utilities in 50 states, Arcadia oversees 4.5 terawatt hours (4.5 trillion kilowatt hours) of residential demand for energy. It's the biggest manager of residential solar in the U.S.

Arcadia has raised $70.5 million in funding, according to Crunchbase.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings